Search

Search Results

• 

  The landscape of rare coagulation factor deficiency management in Italy: a national hemophilia center survey

  Silvia Linari, Renato Marino, Marzia Leotta, Antonio Coppola, Patrizia Di Gregorio, Augusto Bramante Federici, Flora Peyvandi, Cristina Santoro, Ezio Zanon, Rita Carlotta Santoro

  05-11-2025

  https://doi.org/10.4081/btvb.2025.369

  1343

  PDF: 216

  HTML: 133

  Appendix: 119
• 

  The night of randomized clinical trials where all patients are black: a need to estimate variability in treatment effects

  Giovanni de Gaetano, Chiara Cerletti, Licia Iacoviello, Maria Benedetta Donati

  22-03-2022

  https://doi.org/10.4081/btvb.2022.24

  2435

  PDF: 435

• CO-10 | APPLICATIONS OF ARTIFICIAL INTELLIGENCE IN HEMOPHILIA MANAGEMENT: INNOVATIONS AND FUTURE PERSPECTIVES A. Ierardi, M. Leotta, A. Strangio, S. Prejanò, R.C. Santoro | UO Hemophilia, Hemostasis and Thrombosis. Azienda Ospedaliero Universitaria Renato Dulbecco, Catanzaro, Italy

  Antonella Ierardi

  14-10-2026

  https://doi.org/10.4081/btvb.2026.620

  70

  PDF: 10
• 

  Next-generation biomarkers for cancer-associated thrombosis prediction: the role of non-genomic-omics

  Jose Manuel Soria, Joan Carles Souto, Andrés Muñoz

  16-04-2026

  https://doi.org/10.4081/btvb.2026.447

  580

  PDF: 152

• CO42 | Oxidative stress may contribute to enhanced thrombopoiesis through miR-150: implications for aspirin response R. Liani¹, P.G.M. Simeone¹, M. Alfonsetti¹, M. Frezza¹, R. Tripaldi¹, S. Ciotti¹, M. Luongo², F. Cipollone¹, L. Vanella³, F. Santilli¹ | ¹Department of Medicine and Aging, and Center for Advanced Studies and Technology “CAST”, G. d’Annunzio University of Chieti-Pescara, Chieti; ²Immunotransfusion Service, Clinical Haematology of Chieti University Hospital, Chieti; ³Department of Drug Sciences, University of Catania, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.248

  570

  PDF: 11
• 

  Development and implementation of a mathematical model for inpatient warfarin dosing: rationale and methods

  Nikolaos Tsaftaridis, Mark Goldin, Kanta Ochani, Todd Levy, Theodoros P. Zanos, Alex C. Spyropoulos

  28-08-2026

  https://doi.org/10.4081/btvb.2026.195

  1128

  PDF: 132
• 

  Pharmacokinetics of extended half-life albumin-fused factor IX and heterogeneous F9 variants in hemophilia B: a retrospective cohort study

  Barbara Lunghi, Massimo Morfini, Silvia Linari, Dario Balestra, Alessio Branchini, Lisa Pieri, Donata Belvini, Laura Banov, Cristina Santoro, Giancarlo Castaman, Francesco Bernardi

  02-03-2026

  https://doi.org/10.4081/btvb.2026.413

  443

  PDF: 126

  Supplementary: 94
• 

  Availability of direct oral anticoagulants testing among Italian anticoagulation clinics: a rapid evolution of clinical practice On behalf of the Italian Federation of Centers for the Diagnosis of Thrombotic Disorders and the Surveillance of the Antithrombotic Therapies

  Daniela Poli, Antonio Ciampa, Valeria De Micheli, Angela Maria Iannone, Giuseppe Malcangi, Giuseppe Rescigno, Cinzia Scarone, Sophie Testa, Marco Marietta

  26-06-2026

  https://doi.org/10.4081/btvb.2026.485

  861

  PDF: 101
• 

  Bioequivalence of von Willebrand factor-containing concentrates: implications for the choice in patients with von Willebrand disease. A position paper from the Italian Association of Hemophilia Centers

  Ezio Zanon, Giancarlo Castaman, Augusto Bramante Federici, Maria Elisa Mancuso, Gianfranco Pasut, Alberto Tosetto, Angiola Rocino, Rita Carlotta Santoro

  26-01-2026

  https://doi.org/10.4081/btvb.2026.415

  1285

  PDF: 342

  HTML: 163